期刊
AMERICAN JOURNAL OF MEDICINE
卷 123, 期 10, 页码 877-884出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.amjmed.2010.02.028
关键词
Drugs; Fractures; Osteoporosis; Secondary osteoporosis
资金
- MIUR
- Centro di Ricerca sull'Osteoporosi-University of Brescia/EULO
- Eli Lilly
- GlaxoSmithKline
- Novartis
- Amgen
- Abiogen
- Merck
- Stroder
Drug-induced osteoporosis is common and has a significant impact on the prognosis of patients suffering from chronic debilitating diseases. Glucocorticoids are the drugs causing osteoporotic fractures most frequently, but osteoporosis with fractures is observed also in women treated with aromatase inhibitors for breast cancer, in men receiving anti-androgen therapy for prostate cancer, in postmenopausal women treated with high doses of thyroxine, and in men and women treated with thiazolinediones for type 2 diabetes mellitus. Bone loss with fractures also occurs in patients treated with drugs targeting the immune system, such as calcineurin inhibitors, antiretroviral drugs, selective inhibitors of serotonin reuptake, anticonvulsants, loop diuretics, heparin, oral anticoagulants, and proton pump inhibitors. (C) 2010 Elsevier Inc. All rights reserved. The American Journal of Medicine (2010) 123, 877-884
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据